Catasys Inc. (NASDAQ:CATS) posted its quarterly earnings results on Tuesday. The company reported ($0.23) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by $0.03, Morningstar.com reports.

Catasys (CATS) traded down 4.50% during trading on Wednesday, reaching $4.46. 10,839 shares of the company traded hands. Catasys has a 52 week low of $3.56 and a 52 week high of $14.00. The firm’s market capitalization is $70.80 million. The company’s 50-day moving average price is $4.45 and its 200 day moving average price is $6.41.

Separately, Zacks Investment Research lowered shares of Catasys from a “hold” rating to a “sell” rating in a research report on Friday, June 9th.

ILLEGAL ACTIVITY NOTICE: “Catasys Inc. (CATS) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.watchlistnews.com/catasys-inc-cats-issues-quarterly-earnings-results/1492296.html.

A number of large investors have recently bought and sold shares of CATS. Perkins Capital Management Inc. acquired a new stake in Catasys during the second quarter worth approximately $113,000. UBS Oconnor LLC acquired a new stake in Catasys during the second quarter worth approximately $834,000. Bard Associates Inc. acquired a new stake in Catasys during the second quarter worth approximately $1,012,000. Kennedy Capital Management Inc. acquired a new stake in Catasys during the second quarter worth approximately $1,385,000. Finally, FNY Partners Fund LP acquired a new stake in Catasys during the second quarter worth approximately $1,560,000. Institutional investors own 2.19% of the company’s stock.

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.